CYP19A1 and neoplasm: In another study that employed identical design and analytical methods to those reported here, similar levels of decreased tumour aromatase activity and tumour oestrogen concentrations were found following the use of neoadjuvant letrozole 2.5 mg daily for 3 months (Miller et al, 1998).